Ordering
Available Variants1 g
CHA.76189-1g
Price
€52.32
Available – Dispatch in 14 days
5 g
CHA.76189-5g
Price
€118.40
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
1 g | CHA.76189-1g | €52.32 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 g | CHA.76189-5g | €118.40 |
≥98% (TLC), powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C21H30BrNO4 |
|---|---|
| CAS Number | 149-64-4 |
| Molecular Weight | 440.37 |
| NACRES | NA.77 |
| PubChem Substance ID | 24277872 |
| UNSPSC Code | 12352116 |
| EC Number | 205-744-1 |
| MDL number | MFCD00078561 |
| Assay | ≥98% (TLC) |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H302 + H332 |
| pcodes | P261 - P264 - P270 - P271 - P301 + P312 - P304 + P340 + P312 |
| Hazard Classifications | Acute Tox. 4 Inhalation - Acute Tox. 4 Oral |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 1 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | dust mask type N95 (US), Eyeshields, Gloves |
Technical Overview & Applications Use-case context
(−)-Scopolamine N-butyl bromide, with a CAS number of 149-64-4, is a quaternary ammonium compound derived from scopolamine, a tropane alkaloid found in various plant species. This compound exhibits anticholinergic properties, acting as a muscarinic receptor antagonist, which can lead to a range of physiological effects including decreased salivation, reduced gastrointestinal motility, and mydriasis. Due to its quaternary structure, (−)-Scopolamine N-butyl bromide is less likely to cross the blood-brain barrier, resulting in a decreased incidence of central nervous system side effects compared to its tertiary counterparts. As a result, this compound has been utilized in various medical applications, including the treatment of gastrointestinal disorders and as a preanesthetic medication to reduce salivation and respiratory secretions. Its chemical properties and pharmacological profile make it a valuable agent in clinical settings.
